Sen. Burr Worries Rising User Fees Helping US FDA Evade Congressional Oversight
Executive Summary
Burr wants more FDA accountability in the new user fee agreements and questions whether they benefit patients. Generic approval modifications get attention at hearing.
You may also be interested in...
US FDA Exploring Furlough Possibility If User Fee Bill Not Enacted In Time
Furloughs would allow affected FDA staff to remain employed, while a layoffs would require affected workers to be rehired.
US FDA Exploring Furlough Possibility If User Fee Bill Not Enacted In Time
Furloughs would allow affected FDA staff to remain employed, while a layoffs would require affected workers to be rehired.
Don’t Expect Abandonment Of US FDA User Fee Programs If They Sunset
Popular characteristics like goal dates are expected to remain in place if Congress does not renew the user fee programs by 1 October.